Clinical Trials Directory

Trials / Completed

CompletedNCT04780763

Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress.

Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress. A Proof-of-efficacy, Randomized, Controlled, Double-blind, Monocentric, Parallel Arms Design Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
168 (actual)
Sponsor
Danone Global Research & Innovation Center · Industry
Sex
Female
Age
20 Years – 30 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the effect of Lactobacillus rhamnosus CNCM I-3690 consumption on subjective anxiety levels in healthy subjects undergoing academic stress.

Conditions

Interventions

TypeNameDescription
OTHERMilk product fermented by lactic bacteria or not fermented2 bottles of 100g consumed daily during 28 days

Timeline

Start date
2021-03-04
Primary completion
2021-09-14
Completion
2021-12-22
First posted
2021-03-03
Last updated
2022-03-23

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04780763. Inclusion in this directory is not an endorsement.